Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1984 Jul;57(1):12–16.

Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus.

P Ruuska, J Ilonen, A Mustonen, A Tiilikainen
PMCID: PMC1536070  PMID: 6235073

Abstract

An immune adherence haemagglutination (IAHA) method was used to measure erythrocyte C3b receptor (EC3bR) activity in 110 patients with insulin-dependent diabetes mellitus (IDDM) and 223 controls. Results obtained from IDDM were correlated with serum complement concentrations (C3, C4) as well as with HLA types of the patients. We observed an increased frequency of defective EC3bR in IDDM (26.4%) compared to controls (10.8%, P less than 0.0005). Those patients who had defective EC3bR (IAHA negative) also had lower serum C3 and C4 concentrations than those with normal EC3bR function (IAHA positive). HLA-Dw3 positive patients had lower C4 concentrations than HLA-Dw3 negative patients and more often had defective EC3bR activity, although this difference was statistically not significant. Our results may indicate the close relationship between the risk factors which predispose to both IDDM and systemic lupus erythematosus.

Full text

PDF
12

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cambon-de Mouzon A., Ohayon E., Hauptmann G., Sevin A., Abbal M., Sommer E., Vergnes H., Ducos J. HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM). Tissue Antigens. 1982 May;19(5):366–379. doi: 10.1111/j.1399-0039.1982.tb01463.x. [DOI] [PubMed] [Google Scholar]
  2. Cudworth A. G., Wolf E. The genetic susceptibility to type I (insulin-dependent) diabetes mellitus. Clin Endocrinol Metab. 1982 Jul;11(2):389–408. doi: 10.1016/s0300-595x(82)80021-2. [DOI] [PubMed] [Google Scholar]
  3. Daha M. R., van Es L. A. The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages. Immunology. 1982 Sep;47(1):203–209. [PMC free article] [PubMed] [Google Scholar]
  4. Dawkins R. L., Uko G., Christiansen F. T., Kay P. H. Low C4 concentrations in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1983 Sep 17;287(6395):839–839. doi: 10.1136/bmj.287.6395.839-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gelfand M. C., Frank M. M., Green I. A receptor for the third component of complement in the human renal glomerulus. J Exp Med. 1975 Oct 1;142(4):1029–1034. doi: 10.1084/jem.142.4.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gigli I., Nelson R. A., Jr Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3. Exp Cell Res. 1968 Jul;51(1):45–67. doi: 10.1016/0014-4827(68)90158-4. [DOI] [PubMed] [Google Scholar]
  7. Henson P. M. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. J Immunol. 1971 Dec;107(6):1535–1546. [PubMed] [Google Scholar]
  8. Huber H., Polley M. J., Linscott W. D., Fudenberg H. H., Müller-Eberhard H. J. Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science. 1968 Dec 13;162(3859):1281–1283. doi: 10.1126/science.162.3859.1281. [DOI] [PubMed] [Google Scholar]
  9. Iida K., Mornaghi R., Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med. 1982 May 1;155(5):1427–1438. doi: 10.1084/jem.155.5.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ilonen J., Reunanen M., Salmi A., Tiilikainen A. Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis. J Neurol Sci. 1981 Jan;49(1):117–133. doi: 10.1016/0022-510x(81)90194-5. [DOI] [PubMed] [Google Scholar]
  11. Laurent M. R., Welsh K. I. Genetic markers in rheumatological diseases. J Immunogenet. 1983 Aug;10(4):275–291. doi: 10.1111/j.1744-313x.1983.tb00805.x. [DOI] [PubMed] [Google Scholar]
  12. Lay W. H., Nussenzweig V. Receptors for complement of leukocytes. J Exp Med. 1968 Nov 1;128(5):991–1009. doi: 10.1084/jem.128.5.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mantovani B., Rabinovitch M., Nussenzweig V. Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG). J Exp Med. 1972 Apr 1;135(4):780–792. doi: 10.1084/jem.135.4.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McCluskey J., McCann V. J., Kay P. H., Zilko P. J., Christiansen F. T., O'Neill G. J., Dawkins R. L. HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia. 1983 Mar;24(3):162–165. doi: 10.1007/BF00250155. [DOI] [PubMed] [Google Scholar]
  15. Medof M. E., Iida K., Mold C., Nussenzweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med. 1982 Dec 1;156(6):1739–1754. doi: 10.1084/jem.156.6.1739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Medof M. E., Lam T., Prince G. M., Mold C. Requirement for human red blood cells in inactivation of C3b in immune complexes and enhancement of binding to spleen cells. J Immunol. 1983 Mar;130(3):1336–1340. [PubMed] [Google Scholar]
  17. Medof M. E., Prince G. M. Alternative pathway-mediated rebinding of immune complexes to human red blood cells. Immunology. 1983 Sep;50(1):1–9. [PMC free article] [PubMed] [Google Scholar]
  18. Miyakawa Y., Yamada A., Kosaka K., Tsuda F., Kosugi E., Mayumi M. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet. 1981 Sep 5;2(8245):493–497. doi: 10.1016/s0140-6736(81)90882-5. [DOI] [PubMed] [Google Scholar]
  19. Mäkelä A. L., Eerola E., Lehtonen O. P., Ruuska P., Lantto R. Erythrocyte C3b receptors in juvenile rheumatoid arthritis. N Engl J Med. 1983 Sep 15;309(11):673–673. doi: 10.1056/NEJM198309153091123. [DOI] [PubMed] [Google Scholar]
  20. NELSON R. A., Jr The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science. 1953 Dec 18;118(3077):733–737. doi: 10.1126/science.118.3077.733. [DOI] [PubMed] [Google Scholar]
  21. Schuyler M. R., Steinberg D. Activated alveolar macrophages: IgG and complement receptors. J Lab Clin Med. 1982 Dec;100(6):932–942. [PubMed] [Google Scholar]
  22. Vergani D., Johnston C., B-Abdullah N., Barnett A. H. Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes? Br Med J (Clin Res Ed) 1983 Mar 19;286(6369):926–928. doi: 10.1136/bmj.286.6369.926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wilson J. G., Tedder T. F., Fearon D. T. Characterization of human T lymphocytes that express the C3b receptor. J Immunol. 1983 Aug;131(2):684–689. [PubMed] [Google Scholar]
  24. Wilson J. G., Wong W. W., Schur P. H., Fearon D. T. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med. 1982 Oct 14;307(16):981–986. doi: 10.1056/NEJM198210143071604. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES